Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05339594 · ClinicalTrials.gov registry record
REINVENT Registry (Registry of the Nerve Gap Repair From Integra)
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- 17
- Enrollment target
NCT05339594 is a clinical trial that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 17 participants.
The verdict
NCT05339594 was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- 17 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, observational registry designed to evaluate two of Integra's collagen nerve gap repair products (NeuraGen® Nerve Guide and NeuraGen® 3D Nerve Guide Matrix). This registry will collect data on the outcome measures throughout the follow-up period for each patient. Data will be collected per standard of care.
Interventions
- DEVICE NeuraGen
- DEVICE NeuraGen 3D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2022-05-30 |
| Est. Completion | 2024-06-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05339594
The ClinicalTrials.gov registry entry for NCT05339594 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which NeuraGen is the first listed.
NCT05339594 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05339594 about?
NCT05339594 is a clinical study titled "REINVENT Registry (Registry of the Nerve Gap Repair From Integra)". This is a prospective, multi-center, observational registry designed to evaluate two of Integra's collagen nerve gap repair products (NeuraGen® Nerve Guide and NeuraGen® 3D Nerve Guide Matrix). This registry will collect data on the outcome measures throughout the follow-up period for each patient. ...
What is the current status of trial NCT05339594?
This trial is currently terminated. The enrollment target is 17 participants. The study started on 2022-05-30. Estimated completion is 2024-06-03.
What interventions are being tested in trial NCT05339594?
The interventions under investigation include: NeuraGen (DEVICE), NeuraGen 3D (DEVICE).
Who is sponsoring clinical trial NCT05339594?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.